Archive for the 'Irritable Bowel Syndrome' Category
Invivodata’s EPRO Solution Captures Primary Efficacy Data Supporting Supplemental Approval Of Sucampo’s AMITIZA For A New Indication
invivodata inc., the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, announced that its ePRO solutions - DiaryPRO® and SitePRO® - captured primary efficacy data that supported the recent U.S. Food and Drug Administration’s (FDA) supplemental approval of Sucampo Pharmaceutical Inc.Original post by Diabetes Mine
No commentsNew NICE Guidelines Mean IBS Sufferers Will Be Tested For Coeliac Disease, UK
The symptoms of IBS and coeliac disease can often be very similar as a result the diagnosis of coeliac disease can be delayed or missed and IBS is misdiagnosed.Original post by Diabetes Notes
No commentsAnti-depressants May Benefit Some Patients With Irritable Bowel Disease
Theories abound about the cause of Irritable Bowel Disease (IBD): Diet? Stress? Perhaps an infection? On the other hand, is it possible depression could be triggering the disease in some of the 20 per cent of Canadians suffering from this digestive system disorder? New research conducted by scientists in McMaster University’s Intestinal Disease Research Program suggests it’s highly likely that in some patients depression is wreaking havoc on the gut.Original post by Diabetes Notes
No commentsAntidepressant Found To Alleviate Symptoms Of Irritable Bowel Syndrome In Adolescents
Researchers at Mattel Children’s Hospital UCLA have found that low-dose antidepressant therapy can significantly improve the overall quality of life for adolescents suffering from irritable bowel syndrome, or IBS.The syndrome affects 6 percent of middle school students and 14 percent of high school kids in the United States.Original post by Diabetes Mine
No commentsSucampo Pharmaceuticals Obtains FDA Approval For AMITIZA(R) For The Treatment Of Irritable Bowel Syndrome With Constipation In Adult Women
Sucampo Pharmaceuticals, Inc., (NASDAQ: SCMP, Sucampo Pharmaceuticals) and Takeda Pharmaceutical Company Limited (TSE: 4502, Takeda) and its wholly owned subsidiary, Takeda Pharmaceuticals North America, Inc., announced that the U.S.Original post by Diabetes Update
No commentsFDA Approves Amitiza For IBS-C - Only Drug Available In USA For Irritable Bowel Syndrome With Constipation
The U.S. Food and Drug Administration approved Amitiza (lubiprostone) for the treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in adult women aged 18 and over. There is currently no prescription drug therapy for IBS-C. With this approval, Amitiza becomes the only FDA-approved medical treatment for IBS-C available in the United States. Irritable bowel syndrome is a disorder characterized by cramping, abdominal pain, bloating, constipation, and diarrhea.Original post by Diabetes Notes
No commentsCallisto Pharmaceuticals Files IND For SP-304 (Guanilib) In Chronic Constipation And Irritable Bowel Syndrome
Callisto Pharmaceuticals, Inc. (AMEX: KAL; FWB: CA4) announced that through its wholly-owned subsidiary, Synergy Pharmaceuticals, Inc. it filed an IND on April 2, 2008 with the FDA for SP-304 (also called Guanilib) for the treatment of chronic constipation and constipation-predominant irritable bowel syndrome. SP-304 is an analog of uroguanylin, a natural hormone produced in the gastro-intestinal (GI) tract that is a key regulator of intestinal function.Original post by Diabetes Notes
No commentsFood For Life Baking Co., Inc. Recalls Spelt Bread , California - Product Contains Undeclared Wheat
Food For Life Baking Company of Corona, California is voluntarily recalling 2,241 cases of Spelt Bread (UPC# 07347200168) because they contain spelt grain which is known to be a hybrid of wheat. People who have allergies to wheat or those with Celiac Disease may run the risk of a serious or life threatening allergic reaction if they consume spelt products. The recalled products were sold nationwide through health food distributors and natural food retailers.Original post by Women’s Bioethics Blog
No commentsAbuse History Affects Pain Regulation In Women With Irritable Bowel Syndrome
UCLA and University of North Carolina researchers have found that women with irritable bowel syndrome (IBS) who have experienced sexual and/or physical abuse may have a heightened brain response to pain that makes them more sensitive to abdominal discomfort. IBS is a condition that affects 10 to 15 percent of the population and causes gastrointestinal discomfort along with diarrhea, constipation or both.Original post by Diabetes Notes
No commentsAllergic Disease Linked To Irritable Bowel Syndrome
Adults with allergy symptoms report a high incidence of Irritable Bowel Syndrome (IBS), suggesting a link between atopic disorders and IBS according to a study published this month in Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).In a study of 125 adults, Mary C. Tobin, M.Original post by Six Until Me.
No comments